Stonehenge Partners Corp

Search
⚲

Stonehenge Partners Corp ✚
CRD #	333491
SEC #	802-131608
CIK #	0001638279
AUM
Employees
Phone	614-246-2500
Address	191 W Nationwide Blvd Columbus, OH 43215
Source	[IAPD] [EDGAR] [Website]

Total AUM ($) Copy

Type	Form D Funds	Date	Sold	AUM
PE	Stonehenge Opportunity Fund III-B LP	2024-11-11		6.5 M
PE	Stonehenge Opportunity Fund III LP	2024-11-11		39.6 M
Other	Stonehenge Opportunity Fund IV LP	[2024-11-11]	81.5 M	266.2 M
	Offered $125,000,000 · Filed 2016-05-19 (D) · Exemption 506(b) · Minimum $100,000 · Remaining $43,488,000 · Duration One year or less · Net Assets Decline to Disclose
Other	Stonehenge Opportunity Fund V LP	[2024-11-11]	139.1 M	281.3 M
	Filed 2023-03-01 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose

AUM Breakdown	Accounts	AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	0	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	0	0.0
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	0	0.0
By Discretionary
Discretionary	0	0.0
Non-Discretionary	0	0.0
Total	0	0.0
By Non-United States Persons
Non-United States Persons		0.0
United States Persons		0.0
Total	0	0.0

Form D Directors	Role	# Filings	# Firms
Peter Davies	Executive Officer	19	2
David Meuse	Executive Officer	13	2
Thomas Utgard	Executive Officer	2	1
Robert Eversole	Executive Officer	2	1
Corp Stonehenge Partners	Promoter	1	1
Stephen Kimpel	Executive Officer	1	1
Michael Endres	Executive Officer	1	1
Stonehenge Equity Partners V	Executive Officer	1	1
Andrew Bohutinsky	Executive Officer	1	1

EDGAR Form	CIK	2011 - 2026
3	[0001638279]
4	[0001638279]
SC 13G	[0001638279]

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Stonehenge Partners LLC	Ritter Pharmaceuticals Inc	[2016-02-25]

Firm Profile (Form ADV)
Fund Types	Private Equity

Form 3/4/5 Subject	2011 - 2026
Stonehenge Partners LLC
Ritter Pharmaceuticals Inc

Insider Transaction (Form 3/4/5)	Date	Action	Shares	Price	Value ($)
Ritter Pharmaceuticals Inc RTTR Common Stock	2015-06-29	Conversion	817,272
Ritter Pharmaceuticals Inc RTTR Convertible Preferred Stock · derivative	2015-06-29	Conversion	817,272	$0.00

{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}

Stonehenge Partners Corp

Assets, Funds, Holdings